Jordan I - Search Results

1

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.

Carnell GW, Billmeier M, Vishwanath S, Suau Sans M, Wein H, George CL, Neckermann P, Del Rosario JMM, Sampson AT, Einhauser S, Aguinam ET, Ferrari M, Tonks P, Nadesalingam A, Schütz A, Huang CQ, Wells DA, Paloniemi M, Jordan I, Cantoni D, Peterhoff D, Asbach B, Sandig V, Temperton N, Kinsley R, Wagner R, Heeney JL. Carnell GW, et al. Among authors: jordan i. Front Immunol. 2023 Feb 23;14:1118523. doi: 10.3389/fimmu.2023.1118523. eCollection 2023. Front Immunol. 2023. PMID: 36911730 Free PMC article.

2

An avian cell line designed for production of highly attenuated viruses.

Jordan I, Vos A, Beilfuss S, Neubert A, Breul S, Sandig V. Jordan I, et al. Vaccine. 2009 Jan 29;27(5):748-56. doi: 10.1016/j.vaccine.2008.11.066. Epub 2008 Dec 9. Vaccine. 2009. PMID: 19071186

3

Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin.

Schwarzer J, Rapp E, Hennig R, Genzel Y, Jordan I, Sandig V, Reichl U. Schwarzer J, et al. Among authors: jordan i. Vaccine. 2009 Jul 9;27(32):4325-36. doi: 10.1016/j.vaccine.2009.04.076. Epub 2009 May 14. Vaccine. 2009. PMID: 19410619

4

Cell lines from the Egyptian fruit bat are permissive for modified vaccinia Ankara.

Jordan I, Horn D, Oehmke S, Leendertz FH, Sandig V. Jordan I, et al. Virus Res. 2009 Oct;145(1):54-62. doi: 10.1016/j.virusres.2009.06.007. Epub 2009 Jun 18. Virus Res. 2009. PMID: 19540275 Free PMC article.

5

A chemically defined production process for highly attenuated poxviruses.

Jordan I, Northoff S, Thiele M, Hartmann S, Horn D, Höwing K, Bernhardt H, Oehmke S, von Horsten H, Rebeski D, Hinrichsen L, Zelnik V, Mueller W, Sandig V. Jordan I, et al. Biologicals. 2011 Jan;39(1):50-8. doi: 10.1016/j.biologicals.2010.11.005. Epub 2011 Jan 15. Biologicals. 2011. PMID: 21237672

6

Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses.

Jordan I, Sandig V. Jordan I, et al. BMC Proc. 2011 Nov 22;5 Suppl 8(Suppl 8):O1. doi: 10.1186/1753-6561-5-S8-O1. eCollection 2011. BMC Proc. 2011. PMID: 22373097 Free PMC article. No abstract available.

7

Authentication of the R06E fruit bat cell line.

Jordan I, Munster VJ, Sandig V. Jordan I, et al. Viruses. 2012 May;4(5):889-900. doi: 10.3390/v4050889. Epub 2012 May 23. Viruses. 2012. PMID: 22754654 Free PMC article.

8

Fucose-targeted glycoengineering of pharmaceutical cell lines.

Ogorek C, Jordan I, Sandig V, von Horsten HH. Ogorek C, et al. Among authors: jordan i. Methods Mol Biol. 2012;907:507-17. doi: 10.1007/978-1-61779-974-7_29. Methods Mol Biol. 2012. PMID: 22907371

9

A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium.

Jordan I, Horn D, John K, Sandig V. Jordan I, et al. Viruses. 2013 Jan 21;5(1):321-39. doi: 10.3390/v5010321. Viruses. 2013. PMID: 23337383 Free PMC article.

10

Matrix and backstage: cellular substrates for viral vaccines.

Jordan I, Sandig V. Jordan I, et al. Viruses. 2014 Apr 11;6(4):1672-700. doi: 10.3390/v6041672. Viruses. 2014. PMID: 24732259 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page